Skip to main content
Erschienen in: Clinical and Experimental Nephrology 4/2013

01.08.2013 | Original Article

Effects of amino acids and albumin on erythropoietin carbamoylation

verfasst von: Kyubok Jin

Erschienen in: Clinical and Experimental Nephrology | Ausgabe 4/2013

Einloggen, um Zugang zu erhalten

Abstract

Background

Anemia in chronic renal failure results from inadequate production of erythropoietin and decrease in its biological activity, and the reduced activity of erythropoietin is caused by the presence of plasma inhibitors of erythropoietin. It is reported that one of the inhibitors of erythropoietin is cyanate, a potential uremic toxin formed spontaneously from increased urea due to decreased renal function, and erythropoietin loses its biological activity due to negatively charged cyanate. The purpose of this study is to investigate the protective effects of amino acids, positively charged amino groups, and albumin binding of several toxins on erythropoietin carbamoylation.

Methods

The degree of change in erythropoietin structure by cyanate was measured by the trinitrobenzenesulphonate reaction and Western blotting. The loss of biological activity of erythropoietin caused by cyanate was measured by injecting erythropoietin into rats with chronic renal failure.

Results

The free amino groups in erythropoietin decreased under cyanate treatment in a time- and concentration-dependent manner. In the cyanate treatment group, of the twenty amino acids, phenylalanine, valine, tryptophan, threonine, and lysine prevented the structural modification of erythropoietin, according to Western blot analysis. In addition, of the three proteins, albumin prevented the structural modification of erythropoietin. As for the cyanate with erythropoietin treatment group, only lysine and albumin prevented the loss of biological activity of erythropoietin in the rats.

Conclusion

The results of this study suggest that lysine and albumin may play a protective role against renal anemia by erythropoietin carbamoylation in chronic renal failure.
Literatur
1.
Zurück zum Zitat Thorp ML, Eastman L, Smith DH, et al. Managing the burden of chronic kidney disease. Dis Manag. 2006;9:115–21.PubMedCrossRef Thorp ML, Eastman L, Smith DH, et al. Managing the burden of chronic kidney disease. Dis Manag. 2006;9:115–21.PubMedCrossRef
2.
Zurück zum Zitat IV. NKF-K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: update 2000. Am J Kidney Dis 2001; 37: S182–S238. IV. NKF-K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: update 2000. Am J Kidney Dis 2001; 37: S182–S238.
3.
Zurück zum Zitat Wallner SF, Vautrin RM. Evidence that inhibition of erythropoiesis is important in the anemia of chronic renal failure. J Lab Clin Med. 1981;97:170–8.PubMed Wallner SF, Vautrin RM. Evidence that inhibition of erythropoiesis is important in the anemia of chronic renal failure. J Lab Clin Med. 1981;97:170–8.PubMed
4.
Zurück zum Zitat Mun KC, Golper TA. Impaired biological activity of erythropoietin by cyanate carbamylation. Blood Purif. 2000;18:13–7.PubMedCrossRef Mun KC, Golper TA. Impaired biological activity of erythropoietin by cyanate carbamylation. Blood Purif. 2000;18:13–7.PubMedCrossRef
5.
Zurück zum Zitat Park KD, Mun KC, Chang EJ, et al. Inhibition of erythropoietin activity by cyanate. Scand J Urol Nephrol. 2004;38:69–72.PubMedCrossRef Park KD, Mun KC, Chang EJ, et al. Inhibition of erythropoietin activity by cyanate. Scand J Urol Nephrol. 2004;38:69–72.PubMedCrossRef
6.
Zurück zum Zitat Marier JR, Rose D. Determination of cyanate, and a study of its accumulation in aqueous solutions of urea. Anal Biochem. 1964;7:304–14.PubMedCrossRef Marier JR, Rose D. Determination of cyanate, and a study of its accumulation in aqueous solutions of urea. Anal Biochem. 1964;7:304–14.PubMedCrossRef
7.
Zurück zum Zitat Fluckiger R, Harmon W, Meier W, et al. Hemoglobin carbamylation in uremia. N Engl J Med. 1981;304:823–7.PubMedCrossRef Fluckiger R, Harmon W, Meier W, et al. Hemoglobin carbamylation in uremia. N Engl J Med. 1981;304:823–7.PubMedCrossRef
8.
Zurück zum Zitat Kraus LM, Jones MR, Kraus AP Jr. Essential carbamoyl-amino acids formed in vivo in patients with end-stage renal disease managed by continuous ambulatory peritoneal dialysis: isolation, identification, and quantitation. J Lab Clin Med. 1998;131:425–31.PubMedCrossRef Kraus LM, Jones MR, Kraus AP Jr. Essential carbamoyl-amino acids formed in vivo in patients with end-stage renal disease managed by continuous ambulatory peritoneal dialysis: isolation, identification, and quantitation. J Lab Clin Med. 1998;131:425–31.PubMedCrossRef
9.
Zurück zum Zitat Stim J, Shaykh M, Anwar F, et al. Factors determining hemoglobin carbamylation in renal failure. Kidney Int. 1995;48:1605–10.PubMedCrossRef Stim J, Shaykh M, Anwar F, et al. Factors determining hemoglobin carbamylation in renal failure. Kidney Int. 1995;48:1605–10.PubMedCrossRef
10.
Zurück zum Zitat Balion CM, Draisey TF, Thibert RJ. Carbamylated hemoglobin and carbamylated plasma protein in hemodialyzed patients. Kidney Int. 1998;53:488–95.PubMedCrossRef Balion CM, Draisey TF, Thibert RJ. Carbamylated hemoglobin and carbamylated plasma protein in hemodialyzed patients. Kidney Int. 1998;53:488–95.PubMedCrossRef
11.
Zurück zum Zitat Nilsson L, Lundquist P, Kagedal B, et al. Plasma cyanate concentrations in chronic renal failure. Clin Chem. 1996;42:482–3.PubMed Nilsson L, Lundquist P, Kagedal B, et al. Plasma cyanate concentrations in chronic renal failure. Clin Chem. 1996;42:482–3.PubMed
12.
Zurück zum Zitat Horkko S, Savolainen MJ, Kervinen K, et al. Carbamylation-induced alterations in low-density lipoprotein metabolism. Kidney Int. 1992;41:1175–81.PubMedCrossRef Horkko S, Savolainen MJ, Kervinen K, et al. Carbamylation-induced alterations in low-density lipoprotein metabolism. Kidney Int. 1992;41:1175–81.PubMedCrossRef
13.
Zurück zum Zitat Allebban Z, Gibson LA, Lange RD, et al. Effects of spaceflight on rat erythroid parameters. J Appl Physiol. 1996;81:117–22.PubMed Allebban Z, Gibson LA, Lange RD, et al. Effects of spaceflight on rat erythroid parameters. J Appl Physiol. 1996;81:117–22.PubMed
14.
Zurück zum Zitat Vanholder R, Argiles A, Baurmeister U, et al. Uremic toxicity: present state of the art. Int J Artif Organs. 2001;24:695–725.PubMed Vanholder R, Argiles A, Baurmeister U, et al. Uremic toxicity: present state of the art. Int J Artif Organs. 2001;24:695–725.PubMed
15.
Zurück zum Zitat Vanholder R, De Smet R, Glorieux G, et al. Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int. 2003;63:1934–43.PubMedCrossRef Vanholder R, De Smet R, Glorieux G, et al. Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int. 2003;63:1934–43.PubMedCrossRef
16.
Zurück zum Zitat Roxborough HE, Millar CA, McEneny J, et al. Carbamylation inhibits the ferroxidase activity of ceruloplasmin. Biochem Biophys Res Commun. 1995;214:1073–8.PubMedCrossRef Roxborough HE, Millar CA, McEneny J, et al. Carbamylation inhibits the ferroxidase activity of ceruloplasmin. Biochem Biophys Res Commun. 1995;214:1073–8.PubMedCrossRef
17.
Zurück zum Zitat Wynckel A, Randoux C, Millart H, et al. Kinetics of carbamylated haemoglobin in acute renal failure. Nephrol Dial Transplant. 2000;15:1183–8.PubMedCrossRef Wynckel A, Randoux C, Millart H, et al. Kinetics of carbamylated haemoglobin in acute renal failure. Nephrol Dial Transplant. 2000;15:1183–8.PubMedCrossRef
19.
Zurück zum Zitat Kraus LM, Kraus AP Jr. Carbamoylation of amino acids and proteins in uremia. Kidney Int Suppl. 2001;78:S102–7.PubMedCrossRef Kraus LM, Kraus AP Jr. Carbamoylation of amino acids and proteins in uremia. Kidney Int Suppl. 2001;78:S102–7.PubMedCrossRef
20.
Zurück zum Zitat Stark GR. On the reversible reaction of cyanate with sulfhydryl groups and the determination of NH2-terminal cysteine and cystine in proteins. J Biol Chem. 1964;239:1411–4.PubMed Stark GR. On the reversible reaction of cyanate with sulfhydryl groups and the determination of NH2-terminal cysteine and cystine in proteins. J Biol Chem. 1964;239:1411–4.PubMed
21.
Zurück zum Zitat Stark GR, Smyth DG. The use of cyanate for the determination of NH2-terminal residues in proteins. J Biol Chem. 1963;238:214–26.PubMed Stark GR, Smyth DG. The use of cyanate for the determination of NH2-terminal residues in proteins. J Biol Chem. 1963;238:214–26.PubMed
22.
Zurück zum Zitat Stark GR. Reactions of cyanate with functional groups of proteins. 3. Reactions with amino and carboxyl groups. Biochemistry. 1965;4:1030–6.PubMedCrossRef Stark GR. Reactions of cyanate with functional groups of proteins. 3. Reactions with amino and carboxyl groups. Biochemistry. 1965;4:1030–6.PubMedCrossRef
23.
Zurück zum Zitat Satake R, Kozutsumi H, Takeuchi M, et al. Chemical modification of erythropoietin: an increase in in vitro activity by guanidination. Biochim Biophys Acta. 1990;1038:125–9.PubMedCrossRef Satake R, Kozutsumi H, Takeuchi M, et al. Chemical modification of erythropoietin: an increase in in vitro activity by guanidination. Biochim Biophys Acta. 1990;1038:125–9.PubMedCrossRef
24.
Zurück zum Zitat Park KD, Park SB, Choi HJ, et al. Effect of amino acids and albumin of damage induced by cyanate in osteoblast. Korean J Nephrol. 2007;26:404–13. Park KD, Park SB, Choi HJ, et al. Effect of amino acids and albumin of damage induced by cyanate in osteoblast. Korean J Nephrol. 2007;26:404–13.
Metadaten
Titel
Effects of amino acids and albumin on erythropoietin carbamoylation
verfasst von
Kyubok Jin
Publikationsdatum
01.08.2013
Verlag
Springer Japan
Erschienen in
Clinical and Experimental Nephrology / Ausgabe 4/2013
Print ISSN: 1342-1751
Elektronische ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-012-0751-y

Weitere Artikel der Ausgabe 4/2013

Clinical and Experimental Nephrology 4/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Schadet Ärger den Gefäßen?

14.05.2024 Arteriosklerose Nachrichten

In einer Studie aus New York wirkte sich Ärger kurzfristig deutlich negativ auf die Endothelfunktion gesunder Probanden aus. Möglicherweise hat dies Einfluss auf die kardiovaskuläre Gesundheit.

Intervallfasten zur Regeneration des Herzmuskels?

14.05.2024 Herzinfarkt Nachrichten

Die Nahrungsaufnahme auf wenige Stunden am Tag zu beschränken, hat möglicherweise einen günstigen Einfluss auf die Prognose nach akutem ST-Hebungsinfarkt. Darauf deutet eine Studie an der Uniklinik in Halle an der Saale hin.

Klimaschutz beginnt bei der Wahl des Inhalators

14.05.2024 Klimawandel Podcast

Auch kleine Entscheidungen im Alltag einer Praxis können einen großen Beitrag zum Klimaschutz leisten. Die neue Leitlinie zur "klimabewussten Verordnung von Inhalativa" geht mit gutem Beispiel voran, denn der Wechsel vom klimaschädlichen Dosieraerosol zum Pulverinhalator spart viele Tonnen CO2. Leitlinienautor PD Dr. Guido Schmiemann erklärt, warum nicht nur die Umwelt, sondern auch Patientinnen und Patienten davon profitieren.

Zeitschrift für Allgemeinmedizin, DEGAM

Typ-2-Diabetes und Depression folgen oft aufeinander

14.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes sind überdurchschnittlich gefährdet, in den nächsten Jahren auch noch eine Depression zu entwickeln – und umgekehrt. Besonders ausgeprägt ist die Wechselbeziehung laut GKV-Daten bei jüngeren Erwachsenen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.